and another of spontaneous retropharyngeal hematoma post-thrombolysis for ischemic stroke in patients taking ticagrelor.
A 76-year-old woman developed sudden onset left facial droop, left hemiparesis, and dysarthria. She had an ST-segment elevation myocardial infarction three months prior to presentation treated with a coronary stent and remained on ticagrelor. On arrival to hospital 50 minutes after stroke onset, symptoms had improved to NIHSS 2 (facial droop and dysarthria). CT brain scan revealed no parenchymal changes, a hyperdense thrombus occluding a Sylvian branch of the middle cerebral artery (Figure 1(a) ). CT perfusion imaging demonstrated a 23-mL perfusion lesion with no ischemic core (Figure 1(b) ). After discussing risks and benefits with the patient and her husband, she received alteplase 90 min after onset of symptoms. After 2 h, the patient deteriorated rapidly with severe headache, vomiting, and return of left hemiparesis. Repeat CT brain scan showed a large intracranial hemorrhage with significant midline shift (Figure 1(c) ). After an urgent family meeting, a palliative approach was taken and the patient passed away few hours later.
An 82-year-old male with history of hypertension, hyperlipidemia, coronary artery disease, and myocardial infarction presented with acute onset left hemiparesis, dysarthria, and right gaze deviation (NIHSS 17). CT brain scan showed a hyperdense right MCA and alteplase was commenced. Swelling of the left neck rapidly developed, alteplase was stopped and urgent CT neck scan demonstrated a 1.8 Â 3.5 Â 8.3 cm retropharyngeal hematoma located anterior to C2-C5 vertebral body with mass effect on the supraglottic airway and lateral extension into the left sternocleidomastoid 3.4 Â 6 Â 12.6 cm intramuscular hematoma (Figure 1(d) ). He was electively intubated for airway protection and underwent successful mechanical thrombectomy. He also developed left thigh and frontal periorbital hematomas and required two units blood transfusion. He improved and was transferred to inpatient rehabilitation followed by eventual discharge home.
Ticagrelor is increasingly used in cardiology and is being trialed for secondary stroke prevention with results expected this year. 3 These cases of an unusual retropharyngeal hematoma and fatal SICH in an otherwise low-risk mild stroke patient treated soon after onset with no evidence of ischemic injury on non-contrast and CT perfusion imaging demonstrate a need to closely monitor thrombolysis safety in patients taking ticagrelor as experience develops.
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